HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brendan C Dickson Selected Research

Soft Tissue Neoplasms

1/2021Unclassified low grade spindle cell sarcoma with storiform pattern characterized by recurrent novel EWSR1/FUS-NACC1 fusions.
1/2019Targeted RNA sequencing: A routine ancillary technique in the diagnosis of bone and soft tissue neoplasms.
6/2013Sirtuin 1 (SIRT1): a potential immunohistochemical marker and therapeutic target in soft tissue neoplasms with myoid differentiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brendan C Dickson Research Topics

Disease

72Neoplasms (Cancer)
12/2022 - 06/2007
22Sarcoma (Soft Tissue Sarcoma)
01/2022 - 06/2013
4Breast Neoplasms (Breast Cancer)
01/2022 - 06/2007
4Endometrial Stromal Sarcoma
01/2022 - 04/2019
4Leiomyosarcoma
01/2022 - 06/2013
4Neoplasm Metastasis (Metastasis)
01/2022 - 01/2018
4Osteosarcoma (Osteogenic Sarcoma)
01/2020 - 06/2013
4Necrosis
01/2018 - 09/2003
3Glomus Tumor (Glomus Tumors)
01/2022 - 06/2013
3Carcinoma (Carcinomatosis)
12/2021 - 06/2017
3Soft Tissue Neoplasms
01/2021 - 06/2013
3Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 02/2011
3Ewing Sarcoma (Sarcoma, Ewing)
01/2020 - 06/2013
3Alveolar Soft Part Sarcoma
01/2018 - 02/2011
2Carcinogenesis
12/2022 - 10/2015
2Giant Cell Tumors (Giant Cell Tumor)
11/2022 - 01/2020
2Hemorrhage
11/2022 - 11/2020
2Mesothelioma
10/2022 - 11/2020
2Adenoid Cystic Carcinoma (Cylindroma)
01/2022 - 09/2021
2Disease Progression
01/2022 - 01/2022
2Desmoplastic Small Round Cell Tumor
10/2021 - 06/2013
2Adenocarcinoma
09/2021 - 01/2019
2Fibrosarcoma
01/2021 - 10/2020
2Giant Cell Tumor of Bone
12/2020 - 04/2008
2Myoepithelioma
11/2020 - 10/2019
2Genetic Translocation (Chromosomal Translocation)
11/2020 - 10/2015
2Neurofibrosarcoma (MPNST)
10/2020 - 06/2013
2Synovial Sarcoma (Synovioma)
01/2020 - 06/2013
2Leiomyoma (Uterine Fibroids)
04/2019 - 06/2013
2Solitary Fibrous Tumors
01/2019 - 06/2013
2Liposarcoma
01/2016 - 06/2013
1Rhabdomyoma
12/2022
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2022
1Endodermal Sinus Tumor (Endodermal Sinus Tumors)
01/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021
1Papilloma (Papillomatosis)
12/2021
1Malignant Mesothelioma
11/2021
1Salivary Gland Neoplasms (Salivary Gland Cancer)
10/2021
1Noninfiltrating Intraductal Carcinoma (DCIS)
09/2021
1Acinar Cell Carcinoma
09/2021
1Mucoepidermoid Carcinoma
09/2021
1Hemangioendothelioma
12/2020
1Vascular Neoplasms (Neoplasms, Vascular)
12/2020
1Angiomatoid Fibrous Histiocytoma
11/2020
1Myofibroma
01/2020
1Synovial Chondromatosis (Synovial Osteochondromatosis)
01/2020

Drug/Important Bio-Agent (IBA)

33RNA (Ribonucleic Acid)IBA
12/2022 - 04/2008
12Keratins (Keratin)IBA
11/2022 - 07/2011
10Biological ProductsIBA
11/2022 - 06/2015
10DesminIBA
11/2022 - 01/2019
9Proteins (Proteins, Gene)FDA Link
12/2022 - 06/2007
7S100 Proteins (S 100 Protein)IBA
01/2022 - 01/2018
6DNA (Deoxyribonucleic Acid)IBA
12/2022 - 02/2011
6Phosphotransferases (Kinase)IBA
01/2021 - 03/2016
6Messenger RNA (mRNA)IBA
01/2020 - 06/2007
4LigandsIBA
02/2014 - 06/2007
3ChromograninsIBA
01/2022 - 01/2020
3Estrogen ReceptorsIBA
01/2022 - 01/2019
3SynaptophysinIBA
01/2022 - 01/2020
3CalponinsIBA
12/2021 - 01/2019
3Progesterone Receptors (Progesterone Receptor)IBA
10/2021 - 01/2019
3Transcription Factors (Transcription Factor)IBA
11/2020 - 10/2015
2Cyclin D1IBA
01/2022 - 01/2021
2ChromatinIBA
01/2022 - 01/2019
2Phenobarbital (Luminal)FDA Link
12/2021 - 09/2021
2Calmodulin-Binding Proteins (Caldesmon)IBA
10/2021 - 01/2020
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
11/2020 - 01/2020
2tyrosine receptor (receptor, tyrosine)IBA
10/2020 - 01/2019
2Immune Checkpoint InhibitorsIBA
01/2020 - 01/2018
2Biomarkers (Surrogate Marker)IBA
09/2010 - 04/2008
1Capsules (Microcapsules)IBA
11/2022
1HemosiderinIBA
11/2022
1AsbestosIBA
10/2022
1Mucin-1 (CA 15-3 Antigen)IBA
01/2022
1GlypicansIBA
01/2022
1CateninsIBA
01/2022
1CAM 5.2 antigenIBA
01/2022
1Cadherins (E-Cadherin)IBA
01/2022
1Estrogens (Estrogen)FDA Link
10/2021
1AS 8IBA
09/2021
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
05/2021
1DystrophinIBA
01/2021
12-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA
12/2020
1ProteomeIBA
12/2020
1Glycine (Aminoacetic Acid)FDA LinkGeneric
12/2020
1Immune Checkpoint ProteinsIBA
01/2020
13' Untranslated Regions (3' UTR)IBA
01/2020
1Macrophage Colony-Stimulating FactorIBA
01/2020
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
01/2020
1Neurofibromin 2 (Merlin)IBA
01/2020
1Phosphopyruvate Hydratase (Enolase)IBA
01/2020

Therapy/Procedure

13Therapeutics
01/2022 - 06/2007
4Drug Therapy (Chemotherapy)
01/2018 - 03/2016
3Radiotherapy
12/2021 - 06/2017
2Hysterectomy
11/2020 - 04/2019
1Surgical Amputation (Amputations)
01/2022
1Immunotherapy
12/2021
1Injections
11/2021
1Uterine Myomectomy
10/2021
1Lasers (Laser)
01/2020